"The Novartis drug Zelnorm(TM) (tegaserod maleate)* today became the first and only prescription medication approved by the U.S. Food and Drug Administration (FDA) for the short-term treatment of women with irritable bowel syndrome (IBS) whose primary bowel symptom is constipation. Until now, no prescription medication has been approved in the United States to treat the multiple symptoms of abdominal pain and discomfort, bloating, and constipation associated with IBS."
can't believe it's moving so slowly right now. THIS IS VERY BIG NEWS. Also the technicals for NVS are all pointing to a very significant upward movement. It's VERY oversold and at support. Where's the interest?! Guess those who get in now will be happy, for sure.